Patent Reform -- S. 1145 and HR 1908 provisions related to apportionment of damages, inequitable conduct, and post-grant/second window. 1) Biosimilars, including S 1695, HR 1956, HR 1038, and HR 5629 -- Generating support for Committee/House consideration of legislation to creat a pathway for the approval of biosimilars that protects patient safety and innovation.
2) Health care reform -- Support legislative efforts to expand access to health care insurance and protecting innovation. 1) Comparative effectiveness provisions -- supporting increased transparency/reporting requirements.
2) Physician gift disclosure provisions
3) Hospital Outpatient Prospective Payment System rule -- Oppose CMS proposal to reduce hospital outpatient reimbursment rates for certain pharmaceuticals from ASP +5 to ASP +4.
CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BIOGEN
601 PENNSYLVANIA AVENUE, NW #720, WASHINGTON, DC, 20004, US
KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committe) KATHLEEN TREGONING (Staff, House Ways and Means Committee) ADAM GLUCK (Staff, Senate HELP Committee)
Staff, House Ways and Means Committee Staff, Senate HELP Committee Staff, House Ways and Means Committee Staff, Senate HELP Committe Staff, House Ways and Means Committee Staff, Senate HELP Committee